BRCA2 and pachyonychia congenita: In patients with familial risk factors, the odds of developing PC increase exponentially with the number of affected first-degree relatives (Becker et al., 2014), with the Breast cancer gene 2 (BRCA2) and Partner and localizer of BRCA2 (PALB2) mutations being the most common (Chen, Roberts & Klein, 2017).